Mark, f., 		Pollard, A., & 		Thomson, A.
(2019).
 Docetaxel use in castrate resistant prostate cancer, how timing of treatment and age of patients affect outcome.
<em>Medical Research Archives, 7</em>(5).
doi:10.18103/mra.v7i5.1911